{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:42:28Z","timestamp":1792633348734,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Radiodermatitis is likely to be an inevitable side effect of radiotherapy (RT) but experiencing pain relief during RT might contribute making treatment more acceptable and less impairing. The current study aimed to assess the subjective perceptions and experiences of skin toxicity in a sample of women undergoing adjuvant RT for breast cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eighty patients were randomly assigned to one out of two groups: treatment (i.e., a newly developed topical product) and control (i.e., standard-of-care). Patients underwent adjuvant RT for 3 weeks. Clinical assessment of radiodermatitis and self-reported levels of pain, relief, and perceptions of treatment response were collected at the initiation of RT (T1), during RT (T2 and T3), and 2 weeks after treatment completion (T4). To assess changes in skin-related QoL, a subgroup of patients completed the Padua Skin-Related QoL questionnaire at T0 (before the initiation of RT) and at T4.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A comparable timing of onset and severity of radiodermatitis during treatment was observed in both groups. The treatment group reported lower levels of pain and higher levels of relief compared to the control group when skin toxicity was at its highest levels (T2 and T3). Independent of the group, levels of perceived improvements in clinical status increased over time, whereas skin-related QoL worsened from T0 to T4.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Current findings outline the relevance of integrating clinical evaluations of radiodermatitis with patients\u2019 subjective experiences of skin toxicity in interventional studies. Moreover, they provide preliminary evidence about the soothing effect of a newly developed topical product, thus supporting its usefulness of as a supportive care.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.645921","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T05:09:28Z","timestamp":1618549768000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The Relevance of Assessing Subjective Experiences of Skin Toxicity During Adjuvant Radiotherapy for Breast Cancer"],"prefix":"10.3389","volume":"11","author":[{"given":"Gioia","family":"Bottesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Stefanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Ambroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Baratto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Cristaudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Giuntoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Maramaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martino","family":"Meneghin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genny","family":"Pozzati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Semenzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Togni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Vidotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2011.10.002","article-title":"Adjuvant radiotherapy on older and oldest breast cancer patients after conservative surgery: a retrospective analysis","volume":"55","author":"Fiorica","year":"2012","journal-title":"Arch Gerontol Geriatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/cncr.11141","article-title":"Compliance with breast-conservation standards for patients with early-stage breast carcinoma","volume":"97","author":"White","year":"2003","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-018-1160-5","article-title":"Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer-the impact of dose distribution and patient related factors","volume":"13","author":"Borm","year":"2018","journal-title":"Radiat Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2019.03.017","article-title":"The impact of radiodermatitis on breast cancer patients\u2019 quality of life during radiotherapy: a prospective cohort study","volume":"58","author":"de Andrade Fuzissaki","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1734","article-title":"A qualitative analysis of acute skin toxicity among breast cancer radiotherapy patients","volume":"20","author":"Schnur","year":"2011","journal-title":"Psycho-Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jaad.2005.08.054","article-title":"Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006","volume":"54","author":"Hymes","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00520-009-0788-y","article-title":"Radiodermatitis prevention with sucralfate in breast cancer: fundamental and clinical studies","volume":"19","author":"Falkowski","year":"2011","journal-title":"Support Care Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/00002820-200212000-00007","article-title":"A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue","volume":"25","author":"Heggie","year":"2002","journal-title":"Cancer Nurs"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-004-1174-9","article-title":"Th\u00eata-Cream\u00ae versus Bepanthol\u00ae lotion in breast cancer patients under radiotherapy","volume":"180","author":"R\u00f6per","year":"2004","journal-title":"Strahlenther Onkol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(01)01576-0","article-title":"Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy","volume":"51","author":"Szumacher","year":"2001","journal-title":"J Radiat Oncol Biol Phys"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.01.031","article-title":"Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4","volume":"79","author":"Miller","year":"2011","journal-title":"J Radiat Oncol Biol Phys"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.2488","article-title":"A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis","volume":"26","author":"Pignol","year":"2008","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2013.05.033","article-title":"A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams","volume":"108","author":"Ulff","year":"2013","journal-title":"Radiother Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.24193\/jebp.2018.1.7","article-title":"The assessment of skin-related QoL in individuals dissatisfied with their skin: Factor structure and responsiveness of the Padua Skin-Related QoL questionnaire","volume":"18","author":"Bottesi","year":"2018","journal-title":"J Evid Based Psychother"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.283","article-title":"Clinical pharmacology for development of topical dermatological products: present and future opportunities for safety and efficacy","volume":"89","author":"Cho","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2016.1206073","article-title":"Topically applied lipid-and surfactant-based nanoparticles in the treatment of skin disorders","volume":"14","author":"Desmet","year":"2017","journal-title":"Expert Opin Drug Delivery"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4103\/apjon.apjon_40_18","article-title":"Skin-related quality of life among Midwestern US community-based women with breast cancer experiencing radiodermatitis","volume":"6","author":"Beamer","year":"2019","journal-title":"Asia-Pacific J Oncol Nurs"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2018.01.008","article-title":"Longitudinal trends in skin-related and global quality of life among women with breast radiodermatitis: a pilot study","volume":"33","author":"Beamer","year":"2018","journal-title":"Eur J Oncol Nurs"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/1049732309334097","article-title":"Breast cancer patients\u2019 experience of external-beam radiotherapy","volume":"19","author":"Schnur","year":"2009","journal-title":"Qual Health Res"},{"key":"B21","first-page":"87","article-title":"Sichuan pepper as a skin \u201cspice\u201d","volume":"29","author":"Artaria","year":"2011","journal-title":"J Appl Cosmet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4236\/jcdsa.2013.31A002","article-title":"Tamarindus indica Xyloglucan","volume":"14","author":"Maramaldi","year":"2011","journal-title":"Cosmetich Technol"},{"key":"B23","article-title":"Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial","volume":"19","author":"Togni","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cosmetics5040059","article-title":"Formulating O\/W Emulsions with Plant-Based Actives: A Stability Challenge for an Effective Product","volume":"5","author":"Semenzato","year":"2018","journal-title":"Cosmetics"},{"key":"B25","first-page":"191","article-title":"The clinical evaluation of chemotherapeutic agents in cancer","volume-title":"Evaluation of Chemotherapeutic Agents","author":"Karnofsky","year":"1949"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy oncology group (RTOG) and the European for research and treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"J Radiat Oncol Biol Phys"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3. 0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18363","article-title":"Dysfunctional coping is related to impaired skin-related quality of life and psychological distress in patients with neurofibromatosis type 1 with major skin involvement","volume":"182","author":"Bottesi","year":"2020","journal-title":"Br J Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(00)00782-3","article-title":"Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13","volume":"48","author":"Fisher","year":"2000","journal-title":"J Radiat Oncol Biol Phys"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3109\/02841869609100721","article-title":"Skin treatment with bepanthen cream versus no cream during radiotherapy: a randomized controlled trial","volume":"35","author":"L\u00f8kkevik","year":"1996","journal-title":"Acta Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S246757","article-title":"Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer","volume":"14","author":"Pointreau","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S214375","article-title":"The Role Of Effective Radiation Therapist\u2013Patient Communication In Alleviating Treatment-Related Pain And Procedural Discomfort During Radiotherapy","volume":"13","author":"Mattarozzi","year":"2019","journal-title":"Patient Prefer Adherence"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/nau.23463","article-title":"Outcome and complications of adjustable continence therapy (ProACT\u2122) after radical prostatectomy: 10 years\u2019 experience in 143 patients","volume":"37","author":"Noordhoff","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.02.043","article-title":"Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran","volume":"149","author":"Geisser","year":"2010","journal-title":"PAIN\u00ae"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.645921\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T05:09:31Z","timestamp":1618549771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.645921\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":34,"alternative-id":["10.3389\/fonc.2021.645921"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.645921","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]},"article-number":"645921"}}